Upper Airway Toning for Improve the Compliance of CPAP
Primary Purpose
Sleep Apnea, Obstructive
Status
Unknown status
Phase
Phase 1
Locations
Spain
Study Type
Interventional
Intervention
CPAP
Upper Airway Toning for Improve the Compliance of CPAP
Sponsored by
About this trial
This is an interventional treatment trial for Sleep Apnea, Obstructive focused on measuring CPAP, Upper Airway Toning, Obstructive Sleep Apnoea
Eligibility Criteria
Inclusion Criteria:
- Patients with OSA using CPAP
Exclusion Criteria:
- Neurological Patients
Sites / Locations
- FisiolisticRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Experimental
Arm Label
Control Group
EXPERIMENTAL GROUP
Arm Description
CPAP
Upper Airway Toning for Improve the Compliance of CPAP
Outcomes
Primary Outcome Measures
CPAP compliance
nominal variable
Secondary Outcome Measures
Sleep Apnea Quality of Life Index (SAQLI) Test
Test of quality of life
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01936038
Brief Title
Upper Airway Toning for Improve the Compliance of CPAP
Official Title
Effectiveness of Upper Airway Toning as Adjuvant Treatment in the Former Period of Adaptation of the Continuous Positive Airway Pressure
Study Type
Interventional
2. Study Status
Record Verification Date
September 2013
Overall Recruitment Status
Unknown status
Study Start Date
June 2013 (undefined)
Primary Completion Date
December 2013 (Anticipated)
Study Completion Date
February 2014 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fisiolistic
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The obstructive sleep apnoea/hypopnoea syndrome (OSAHS) is a breathing disorder which happens at night and consists of the interruption of airflow for more than five seconds. His current treatment by continuous positive pressure nocturnal machine (CPAP) is not curative and therefore the level of compliance is key to patient improvement. Many patients don´t tolerate CPAP by the numerous side effects involved. The Upper Airway Toning is a compendium of non-invasive techniques that aim to assist tolerance and compliance with the CPAP. These techniques are: oropharyngeal exercises executed actively by the patient for the muscle toning of the upper airways, electrostimulation of the muscles in the floor of the mouth, correction of the tongue position, nasal and bronchial fogging, execution of respiratory gymnastics, therapy myofascial in the oropharyngeal muscles, manual therapy in the cervical column,and massage in the diaphragm. All the techniques together seek for a greater or lesser impact on the upper airways hypotony, the hypotony of the tongue and the soft palate, the jaw retrognathism, the mouth breathing, the vertebrobasilar syndrome, the gastroesophageal reflux, the excessive accumulation of secretions in the upper and lower airways, the obstructive and restrictive respiratory problems, the sleeping posture, the hypertonia of the diaphragm due to the excess effort in trying to overcome the respiratory obstruction. All these disfunctions will make easier for the patient to show side effects in the use of CPAP. There will be a double-blind randomized controlled study with 110 individuals. One group will follow the conventional medical treatment with CPAP and the other group medical treatment plus Upper Airway Toning. After six months, the mean improvement between the two groups will be compared.
Detailed Description
OBJECTIVES
Main objective: To increase the percentage of Nasal Continuous Positive Airway Pressure (nCPAP) compliance.
Secondary objectives:
To increase the CPAP's tolerance.
To decrease the CPAP's pressure.
To decrease the daytime sleepiness.
To increase the quality of life related to sleep.
To assess the level of subjective utility of CPAP by the patient.
METHODOLOGY
Type of study: Controlled randomized simple blind study
Randomization of groups
Once the patient is into the study (because s/he has the inclusion criteria and has signed up the informed consent), an opaque envelope is opened in order to know the assigned group.The envelopes are consecutively numbered and the assigned group is randomized through the software.
Group 1 or control group: 55 subjects undergo the CPAP treatment.
Group 2 or study group: 55 subjects undergo the CPAP treatment and Upper Airway Toning.
Homogeneity of groups:
Investigators check out the homogeneity of groups in baseline:
Specific features: Neck circumference, presence or lack of nasal clinic, presence or lack of nasal structural alteration, age, gender, weight, height, BMI, smoking habits.
Polysomnographic parameters: Number of apnea, number of hypo-apneas and Apnea Hypopnea Index (AHI).
Symptoms: Presence or lack of severe comorbidities, level of daily hyper-somnolence, presence of insomnia
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Apnea, Obstructive
Keywords
CPAP, Upper Airway Toning, Obstructive Sleep Apnoea
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
110 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Control Group
Arm Type
Placebo Comparator
Arm Description
CPAP
Arm Title
EXPERIMENTAL GROUP
Arm Type
Experimental
Arm Description
Upper Airway Toning for Improve the Compliance of CPAP
Intervention Type
Other
Intervention Name(s)
CPAP
Intervention Description
CPAP
Intervention Type
Procedure
Intervention Name(s)
Upper Airway Toning for Improve the Compliance of CPAP
Intervention Description
Upper Airway Toning for Improve the Compliance of CPAP
Primary Outcome Measure Information:
Title
CPAP compliance
Description
nominal variable
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Sleep Apnea Quality of Life Index (SAQLI) Test
Description
Test of quality of life
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with OSA using CPAP
Exclusion Criteria:
Neurological Patients
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eduard Estelle, Doctor
Phone
647676131
Email
annabague@hotmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eduard Estelle
Organizational Affiliation
Hospital Universitari General de Catalunya
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Anna Bagué
Organizational Affiliation
Fisiolístic
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Xavier Gironés
Organizational Affiliation
Universitat Internacional de Catalunya
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Montserrat Girabent
Organizational Affiliation
Universitat General de Catalunya
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Eduard Estivill
Organizational Affiliation
Clínica Dexeus
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Francesc Segarra
Organizational Affiliation
Hospital Universitari General de Catalunya
Official's Role
Study Chair
Facility Information:
Facility Name
Fisiolistic
City
Hospitalet de Llobregat
State/Province
Barcelona
ZIP/Postal Code
08901
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anna Maria Bague Cruz, Physio
Phone
34 647676131
Email
annabague@hotmail.com
12. IPD Sharing Statement
Learn more about this trial
Upper Airway Toning for Improve the Compliance of CPAP
We'll reach out to this number within 24 hrs